Overview

Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the rate and extent of absorption of risperidone 1 mg tablets (test) versus Risperdal® (reference) administered as a 1 x 1 mg tablet under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Teva Pharmaceuticals USA
Treatments:
Risperidone